10 gange forøgelse af den daglige eksponering af den aktive metabolit 25- O - desacetylrifabutin.
(once every other day) in combination with PREZISTA/ritonavir (600/100 mg b.i.d.) with an about 10-fold increase in the daily exposure to the active metabolite 25-O-desacetylrifabutin.